|
TRMT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53839996297478E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.74010003575853E-09 |
| Normal-vs-Stage2 |
5.54109999999497E-05 |
| Normal-vs-Stage3 |
2.378100E-04 |
| Normal-vs-Stage4 |
1.104790E-03 |
| Stage1-vs-Stage2 |
8.468400E-01 |
| Stage1-vs-Stage3 |
5.060800E-01 |
| Stage1-vs-Stage4 |
6.380600E-01 |
| Stage2-vs-Stage3 |
7.744600E-01 |
| Stage2-vs-Stage4 |
7.996400E-01 |
| Stage3-vs-Stage4 |
9.856000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77570003145888E-09 |
| Normal-vs-AfricanAmerican |
6.28780000289098E-08 |
| Normal-vs-Asian |
2.626500E-02 |
| Caucasian-vs-AfricanAmerican |
9.153200E-01 |
| Caucasian-vs-Asian |
5.473200E-01 |
| AfricanAmerican-vs-Asian |
5.312600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4649005059274E-10 |
| Normal-vs-Female |
1.025000E-04 |
| Male-vs-Female |
8.937300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.30520000041612E-07 |
| Normal-vs-Extreme_Weight |
5.69300051544985E-10 |
| Normal-vs-Obese |
6.37540000014702E-07 |
| Normal-vs-Extreme_Obese |
6.169800E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.172000E-01 |
| Normal_Weight-vs-Obese |
5.947600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.335000E-01 |
| Extreme_Weight-vs-Obese |
1.843220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.413400E-01 |
| Obese-vs-Extreme_Obese |
8.230800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.644800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.34769999996054E-07 |
| Normal-vs-Age(61-80Yrs) |
6.61849464123065E-11 |
| Normal-vs-Age(81-100Yrs) |
1.88649999954826E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.723800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.238200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.496100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.304110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.074000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.628200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.85749987508177E-10 |
| Normal-VS-Type2 PRCC |
8.69800009795085E-10 |
| Normal-VS-KIRP CIMP |
3.991600E-01 |
| Normal-VS-Unclassified PRCC |
1.157730E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.128610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.570000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.217200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.469790E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.698570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.714400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.90819582357449E-11 |
| Normal-vs-N1 |
7.893800E-02 |
| Normal-vs-N2 |
9.6631000001679E-07 |
| N0-vs-N1 |
6.343400E-03 |
| N0-vs-N2 |
5.307800E-02 |
| N1-vs-N2 |
1.797650E-02 |
|
|
